International Journal of Infection Prevention

International Journal of Infection Prevention

International Journal of Infection Prevention – Call For Papers

Open Access & Peer-Reviewed

Submit Manuscript

Call for Papers

Publish research that strengthens infection prevention and patient safety.

Prevention ImpactEvidence that reduces infection risk.
Implementation FocusMethods linked to real-world practice.
Expert ReviewSingle blind peer review.
Global ReachOpen access visibility worldwide.

Journal at a Glance

ISSN: 2690-4837
DOI Prefix: 10.14302/issn.2690-4837
License: CC BY 4.0
Peer reviewed open access journal

Scope Alignment

Infection prevention, healthcare epidemiology, antimicrobial stewardship, outbreak response, surveillance systems, vaccine policy, WASH, environmental hygiene, and One Health implementation science. We prioritize actionable evidence and measurable impact.

Publishing Model

Open access, single blind peer review, and rapid publication after acceptance and production checks. Metadata validation and DOI registration are included.

Call for Papers

International Journal of Infection Prevention invites high quality submissions that advance infection prevention, healthcare epidemiology, and antimicrobial stewardship across clinical and community settings. We welcome original research, systematic reviews, and implementation studies that reduce infection risk and improve patient safety.

Our editorial focus prioritizes rigorous study design, transparent reporting, and measurable impact on prevention practices and policy.

Priority Themes
  • Healthcare-associated infection surveillance and prevention bundles
  • Antimicrobial stewardship and resistance mitigation strategies
  • Outbreak investigation, response, and containment modeling
  • Infection control in surgical, ICU, and long-term care settings
  • Vaccination programs and implementation effectiveness
  • Environmental hygiene, disinfection, and sterilization science
  • WASH and community infection prevention initiatives
  • Occupational exposure, PPE, and safety protocols
  • Diagnostics, screening, and rapid testing workflows
  • One Health approaches and zoonotic spillover prevention
  • Behavior change, compliance measurement, and IPC training
  • Data-driven surveillance systems and digital reporting tools
Article Types Welcomed

Original Research

Clinical or operational studies with validated endpoints and transparent methods.

Systematic Reviews

Evidence syntheses clarifying prevention strategies or implementation outcomes.

Methods and Tools

New surveillance, diagnostic, or analytic tools with benchmarking.

  • Outbreak reports with clear response timelines
  • Implementation science and quality improvement studies
  • Surveillance reports and antimicrobial use analyses
  • Practice or policy briefs grounded in evidence
What Makes a Strong Submission

Successful submissions present a clear prevention question, robust methodology, and transparent reporting of case definitions and denominators. We value studies that demonstrate measurable reductions in infection risk or improvements in compliance and safety.

Authors should document surveillance protocols, intervention fidelity, and outcome definitions to support reproducibility and real-world adoption.

  • Clear case definitions and standardized denominators
  • Validated surveillance methods and data quality checks
  • Appropriate statistical analysis and handling of confounders
  • Interpretation that links findings to prevention decisions
Why Publish in IJIP

Open Access Visibility

Research reaches clinicians, IPC leaders, and policymakers worldwide.

Single Blind Peer Review

Expert reviewers evaluate rigor with editorial oversight.

Metadata and DOI Support

Structured metadata improves discoverability and citation tracking.

Editorial Guidance

Actionable feedback strengthens reporting quality.

Review and Publication Timeline

Submissions undergo editorial screening for scope fit, methodological rigor, and reporting completeness. Qualified manuscripts move to single blind peer review with subject matter experts.

StageTypical TimingFocus
Initial Screening1 to 2 weeksScope fit and compliance checks
Peer Review3 to 6 weeksMethodology rigor and prevention impact
Revision2 to 4 weeksAuthor responses and refinements
Production2 to 3 weeksCopyediting, proofs, DOI registration
Open Access and APC Overview

IJIP operates under an open access model to ensure infection prevention research is discoverable and reusable. APCs are applied after acceptance and support peer review, production, and archiving services.

Membership options and affordable APC waivers are available for eligible authors. Contact the editorial office at [email protected] for guidance.

Submission Checklist
  • Scope fit confirmed for infection prevention research
  • Case definitions and denominators documented
  • Data availability statement included
  • Ethics approvals and consent described
  • Cover letter explains novelty and prevention relevance
Call for Papers FAQ

Do you accept outbreak reports?

Yes. Outbreak reports with clear timelines and control measures are welcome.

Are preprints allowed?

Yes. Disclose preprints in the cover letter and cite them appropriately.

Do you accept implementation science studies?

Yes. We welcome implementation and quality improvement research.

How do I propose a special issue?

Send a proposal outline to [email protected] for review.

IJIP Commitment

IJIP is committed to rigorous, transparent publishing in infection prevention and control. We emphasize reproducible surveillance methods, clear reporting of case definitions, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in infection prevention science and implementation.

Ready to Submit to IJIP?

Share your infection prevention research with a global, open access audience.